The embattled Spanish drugmaker Grifols SA is in talks with banks to refinance bonds due next year and extend a revolving ...

La farmacéutica española Grifols SA está en conversaciones con bancos para refinanciar bonos que vencen el próximo año y ...

For Spain’s billionaire Grifols family, which turned a blood-collection business into one of the world’s largest medical ...

Shares of Grifols GRFS lost over 7% on Wednesday after the company announced that Canada-based Brookfield Asset Management has withdrawn its plan to acquire it.

The board of Spanish plasma-based medicines producer Grifols has announced the termination of discussions with Brookfield ...

The Board of Directors of Grifols (GRFS) announced the termination of discussions with Brookfield Capital Partners UK regarding a ...

Barcelona-based Grifols has seen its stock value plummet since January when short seller Gotham City Research accused the company of manipulating debt and earnings reporting by consolidating profit ...

The Spanish pharmaceutical company said it considered Brookfield’s offer of 10.50 euros a share undervalued the company and ...

Canadian investment fund Brookfield said Wednesday it has dropped its bid for Spanish Pharmaceutical firm Grifols following ...

Grifols said it plans to outline its strategy as a standalone company after Brookfield Asset Management dropped out of talks ...

Fortress is offering 310p per share, valuing the total equity of the company at around £338 million ($428 million; €406 ...